The Clinical Pharmacology of Anastrozole

@article{Bao2011TheCP,
  title={The Clinical Pharmacology of Anastrozole},
  author={Ting Bao and Michelle A Rudek},
  journal={European Oncology and Haematology},
  year={2011},
  volume={07},
  pages={106}
}
  • Ting Bao, Michelle A Rudek
  • Published 2011
  • Medicine
  • European Oncology and Haematology
  • 13 Citations

    Topics from this paper

    Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancer
    • 14
    Evaluation of Breast Cancer in Reference to Skin Changes 1
    • Dr. Mritunjay Sarawgi, Dr. Sushil Singh, Dr. Anjay Kumar, Dr. Shalini Ekka, D. S. Kumar
    • 2017
    • PDF
    Cyclophosphamide and epirubicin-induced diabetes mellitus in breast cancer: A rare occurrence
    • 5

    References

    SHOWING 1-10 OF 32 REFERENCES
    Effect of simvastatin on the pharmacokinetics of anastrozole.
    • T. Bao, S. Slater, +5 authors V. Stearns
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2009
    • 1
    Liver toxicity after treatment with gefitinib and anastrozole: drug-drug interactions through cytochrome p450?
    • 24
    A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.
    • 1,447
    • PDF
    Pharmacokinetic Drug Interactions of Gefitinib with Rifampicin, Itraconazole and Metoprolol
    • 128
    Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial.
    • 437
    • PDF
    Arimidex®: A potent and selective fourth-generation aromatase inhibitor
    • 150